Collegium Pharmaceutical
Stock Forecast, Prediction & Price Target
Collegium Pharmaceutical (COLL) stock Price Target by analysts
$40
Potential upside: 7.03%
Collegium Pharmaceutical price prediction
What is Collegium Pharmaceutical stock analysts` prediction?
Collegium Pharmaceutical stock forecast: Based on 1 Wall Street analysts` predicted price targets for Collegium Pharmaceutical in the last 3 months, the avarage price target is $40, with a high forecast of $NaN. The average price target represents a 7.03% change from the last price of $37.37.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Collegium Pharmaceutical stock Price Target by analysts
Full breakdown of analysts given Collegium Pharmaceutical price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Glen Santangelo Jefferies | 0% 0/2 | 10 months ago | $40 7.03% upside | $32.18 | StreetInsider | Previous targets (1) |
Oren Livnat H.C. Wainwright | 0% 0/2 | about 1 year ago | $50 33.79% upside | $38.65 | TheFly | Previous targets (1) |
David Amsellem Piper Sandler | 0% 0/2 | about 1 year ago | $37 -0.99% downside | $34.63 | StreetInsider | Previous targets (1) |
Oren Livnat H.C. Wainwright | 0% 0/2 | about 1 year ago | $47 25.76% upside | $38.6 | StreetInsider | Previous targets (1) |
Glen Santangelo Jefferies | 0% 0/2 | about 1 year ago | $44 17.74% upside | $31.36 | StreetInsider | Previous targets (1) |
David Amsellem Piper Sandler | 0% 0/2 | over 1 year ago | $39 4.36% upside | $33.11 | StreetInsider | Previous targets (1) |
Unknown Needham | N/A | over 2 years ago | $35 -6.34% downside | $26.98 | Benzinga | N/A |
Collegium Pharmaceutical Financial Estimates
Collegium Pharmaceutical Revenue Estimates
Collegium Pharmaceutical EBITDA Estimates
Collegium Pharmaceutical Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $276.86M N/A | $463.93M 67.56% | $566.76M 22.16% | Avg: $597.49M Low: $579.82M High: $619.24M avg. 5.42% | Avg: $574.48M Low: $564.23M High: $588.10M avg. -3.85% | Avg: $502.15M Low: $493.19M High: $514.05M avg. -12.59% | Avg: $483.8M Low: $475.16M High: $495.26M avg. -3.65% |
Net Income
% change YoY
| $71.51M N/A | $-25.00M -134.95% | $48.15M 292.60% | Avg: $153.52M Low: $148.34M High: $186.37M avg. 218.81% | Avg: $187.02M Low: $170.91M High: $236.10M avg. 21.82% | Avg: $255.50M Low: $249.57M High: $263.38M avg. 36.61% | Avg: $311.32M Low: $304.09M High: $320.91M avg. 21.84% |
EBITDA
% change YoY
| $22.21M N/A | $34.36M 54.67% | $308.32M 797.18% | Avg: $101.38M Low: $98.38M High: $105.07M avg. -67.11% | Avg: $97.48M Low: $95.74M High: $99.79M avg. -3.85% | Avg: $85.20M Low: $83.68M High: $87.22M avg. -12.59% | Avg: $82.09M Low: $80.62M High: $84.03M avg. -3.65% |
EPS
% change YoY
| $2.05 N/A | -$0.74 -136.09% | $1.6 316.21% | Avg: $3.91 Low: $3.55 High: $4.46 avg. 144.21% | Avg: $4.87 Low: $4.09 High: $5.65 avg. 24.63% | Avg: $6.11 Low: $5.97 High: $6.3 avg. 25.55% | Avg: $7.45 Low: $7.28 High: $7.68 avg. 21.84% |
Operating Expenses
% change YoY
| $128.41M N/A | $176.16M 37.19% | $159.20M -9.62% | Avg: $220.04M Low: $213.53M High: $228.05M avg. 38.21% | Avg: $211.56M Low: $207.79M High: $216.58M avg. -3.85% | Avg: $184.93M Low: $181.63M High: $189.31M avg. -12.59% | Avg: $178.17M Low: $174.99M High: $182.39M avg. -3.65% |
FAQ
What is Collegium Pharmaceutical stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 74.77% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is 148.34M, average is 153.52M and high is 186.37M.
What is Collegium Pharmaceutical stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of -3.66% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $579.82M, average is $597.49M and high is $619.24M.
What is Collegium Pharmaceutical stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 54.06% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is $3.55, average is $3.91 and high is $4.46.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Collegium Pharmaceutical stock. The most successful analyst is Glen Santangelo.